1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 04 MAY 2015

CNS Drug News 04 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Tecfidera Will Be Leading MS Drug In 2015
Industry Brief - Biotie Provides Update On Tozadenant Phase III Programme
Industry Brief - FDA Accepts Zinbryta BLA For MS
Industry Brief - FDA Accepts Filing Of Betaconnect For RRMS Patients Taking Betaseron
Industry Brief - Forward Pharma Receives Decision To Grant From EPO For DMF Patent In Europe
Industry Brief - Phase III Success For Synthon's Glatiramer Acetate
Industry Brief - First Patient Enrolled In Laquinimod Phase II Study For PPMS
Industry Brief - Phase II Study With NeuroSTAT For TBI Passes Safety Evaluation
Industry Brief - Long-Term Data Presented From First Clinical Trial Of ReNeuron's SC Therapy For Stroke
Industry Brief - GW Receives FDA ODD For CBD For NHIE
Industry Brief - Development Of NeuroVive's NVP014 For Stroke Enters New Phase
Industry Brief - Vanda Receives Positive CHMP Opinion On Hetlioz For Non-24
Industry Trend Analysis - US Generic Aripiprazole Competition Will Stress Otsuka's Reliance On Brexpiprazole
Industry Brief - Follow-Up Announcement Made On Preliminary Findings From Lurasidone Phase III Study
Industry Brief - Pain Therapeutics Resumes Responsibility For Remoxy
Industry Brief - FDA Approves Ionsys For Acute Postoperative Pain
Industry Brief - CoLucid Initiates First Phase III Pivotal Trial Of Lasmiditan In Migraine
Industry Brief - Elite Launches Hydroxyzine In US; Completes Dosing In Two ELI-200 Studies
Industry Brief - Study Strengthens Evidence Of Zubsolv's Therapeutic Value
Industry Brief - Eisai Settles US Rufinamide Litigation With Glenmark
Industry Trend Analysis - GW Remains A Risky Investment; Results In H215 Will Be Key
Industry Brief - Two Additional US Patents Issued For Vivus' Qsymia
Industry Brief - Isis Earns USD10mn Milestone Payment From Biogen
Industry Trend Analysis - Biogen Will Continue To Gain Share Of MS Market
Industry Brief - Pernix Closes Acquisition Of Zohydro ER Franchise

Table Of Contents

CNS Drug News 04 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the UK

  • January 2017
    19 pages
  • Therapy  

  • United Kingdom  

View report >

Biological Therapy Industry in the US

  • January 2017
    9 pages
  • Vaccine  

  • United States  

View report >

Hormone Market in the US - Forecast

  • January 2017
    6 pages
  • Hormone  

    Therapy  

  • United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.